136 related articles for article (PubMed ID: 4006317)
1. Cardiovascular effects of brovincamine and possible mechanisms involved.
Kushiku K; Katsuragi T; Mori R; Morishita H; Furukawa T
Clin Exp Pharmacol Physiol; 1985; 12(2):121-30. PubMed ID: 4006317
[TBL] [Abstract][Full Text] [Related]
2. Calcium antagonistic action involved in vasodilation by brovincamine.
Katsuragi T; Ohba M; Mori R; Kushiku K; Furukawa T
Gen Pharmacol; 1984; 15(1):43-5. PubMed ID: 6698382
[TBL] [Abstract][Full Text] [Related]
3. Effects of brovincamine on the autonomic nervous function in the dog and rat.
Kushiku K; Abe M; Katsuragi T; Furukawa T
J Pharmacobiodyn; 1984 Mar; 7(3):177-85. PubMed ID: 6086870
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
Hirohashi M; Takasuna K; Yamashita N; Tamura K
Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of 1-(3,4-dimethoxyphenyl)-2-(4-diphenylmethylpiperazinyl) ethanol and possible mechanisms involved.
Kushiku K; Ohba M; Araki T; Mikagi T; Katsuragi T; Furukawa T
Arzneimittelforschung; 1989 Apr; 39(4):458-63. PubMed ID: 2751731
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular actions of buflomedil and possible mechanisms involved.
Kushiku K; Ohba M; Mikagi T; Nuki S; Araki Y; Furukawa T
Arzneimittelforschung; 1989 Jun; 39(6):670-7. PubMed ID: 2775333
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
Kobinger W; Lillie C
Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920
[TBL] [Abstract][Full Text] [Related]
8. [Effects of CN-100 (2-(10,11-dihydro-10-oxodibenzo [b,f] thiepin-2-yl) propionic acid) on cardiovascular and autonomic nervous function in the dog and guinea pig].
Kushiku K; Abe M; Morishita H; Furukawa T
Nihon Yakurigaku Zasshi; 1989 Nov; 94(5):299-307. PubMed ID: 2613109
[TBL] [Abstract][Full Text] [Related]
9. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase.
Asano T; Suzuki T; Tsuchiya M; Satoh S; Ikegaki I; Shibuya M; Suzuki Y; Hidaka H
Br J Pharmacol; 1989 Dec; 98(4):1091-100. PubMed ID: 2611484
[TBL] [Abstract][Full Text] [Related]
10. Effects of brotizolam on cardiovascular functions and autonomic nervous system.
Kushiku K; Morishita H; Furukawa T; Kitagawa H; Ueno K; Kitagawa H; Kohei H
Arzneimittelforschung; 1986 Mar; 36(3A):552-9. PubMed ID: 3718577
[TBL] [Abstract][Full Text] [Related]
11. [Effects of levocarnitine chloride (LC-80) on the cardiovascular system].
Kirimoto T; Morikawa Y; Yamada H; Fujisawa S; Hironaka Y
Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):155-69. PubMed ID: 2731806
[TBL] [Abstract][Full Text] [Related]
12. [General pharmacology of aclacinomycin A (author's transl)].
Ohmori K; Hirano S; Hori S
Jpn J Antibiot; 1980 Feb; 33(2):192-213. PubMed ID: 6929361
[TBL] [Abstract][Full Text] [Related]
13. The effects of piperidine and its related substances on blood vessels.
Aisaka K; Hattori Y; Ishihara T; Morita M; Kasé Y; Miyata T
Jpn J Pharmacol; 1985 Apr; 37(4):345-53. PubMed ID: 4010086
[TBL] [Abstract][Full Text] [Related]
14. [Effects of the anti-ulcer drug SU-88 on the gastric blood flow and the cardiovascular system (author's transl)].
Saziki R; Arai I; Isobe Y; Aihara H
Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):193-202. PubMed ID: 7084818
[TBL] [Abstract][Full Text] [Related]
15. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
Sassen LM; Soei LK; Koning MM; Verdouw PD
Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
[TBL] [Abstract][Full Text] [Related]
16. [Effects of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propanol (ifenprodil) on the cardiovascular system in vivo].
Mizusawa H; Sakakibara E
Nihon Yakurigaku Zasshi; 1975 Sep; 71(6):597-608. PubMed ID: 1238330
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic profile of a new cerebral vasodilator, vincamine and of one of its derivatives, apovincaminic acid ethylester (RGH-4405).
Caravaggi AM; Sardi A; Baldoli E; Di Francesco GF; Luca TC
Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):139-48. PubMed ID: 869636
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of intravenous pentazocine and cyclazocine in conscious, curarized-conscious, and anesthetized dogs.
Küçukhüseyin C
J Basic Clin Physiol Pharmacol; 2003; 14(3):235-55. PubMed ID: 14964736
[TBL] [Abstract][Full Text] [Related]
19. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
Shintani S; Watanabe K; Kawamura K; Mori T; Tani T; Toba Y; Sasabe H; Nakagiri N; Hongoh O; Fujita S
Arzneimittelforschung; 1985; 35(7A):1163-72. PubMed ID: 3000392
[TBL] [Abstract][Full Text] [Related]
20. Systemic and coronary haemodynamic effects of ketamine in intact anaesthetized and unanaesthetized dogs.
Folts JD; Afonso S; Rowe GG
Br J Anaesth; 1975 Jun; 47(6):686-94. PubMed ID: 1148088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
